A2A Pharmaceuticals, Inc.
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to A2A Pharmaceuticals, Inc.. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| BMEA | Sale | 75,000 | $33.81 | $2,535,750 | Jun 1, 2023 | |
| BMEA | Sale | 25,000 | $33.84 | $846,000 | May 12, 2023 | |
| BMEA | Sale | 150,000 | $34.50 | $5,175,000 | May 8, 2023 | |
| BMEA | Sale | 200,000 | $29.12 | $5,824,000 | Apr 20, 2023 | |
| BMEA | Sale | 200,000 | $31.25 | $6,250,000 | Mar 31, 2023 | |
| BMEA | Sale | 200,000 | $31.25 | $6,250,000 | Mar 31, 2023 | |
| BMEA | Purchase | 30,684 | $13.87 | $425,587 | Aug 16, 2022 | |
| BMEA | Sale | 34,658 | $11.21 | $388,516 | Jul 21, 2022 | |
| BMEA | Sale | 34,658 | $11.76 | $407,578 | Jun 24, 2022 | |
| BMEA | Purchase | 34,658 | $10.96 | $379,852 | Sep 17, 2021 |